Inventor
KIM IN JONG
US48 patents
⚠️ This page may combine multiple inventors who share the name “KIM IN JONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
37 patentsUS9957281B2May 1, 2018
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC32 citations97
US10865215B2Dec 15, 2020
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC16 citations94
US10398706B2Sep 3, 2019
Heteroaryldiazepine derivatives as RSV inhibitors
ENANTA PHARM INC26 citations94
US10358441B2Jul 23, 2019
Processes for the preparation of benzodiazepine derivatives
ENANTA PHARM INC27 citations94
US11912695B2Feb 27, 2024
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC5 citations84
US11572367B2Feb 7, 2023
Antiviral heterocyclic compounds
ENANTA PHARM INC9 citations84
US11505558B1Nov 22, 2022
Antiviral heterocyclic compounds
ENANTA PHARM INC8 citations84
US11390631B1Jul 19, 2022
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC4 citations84
US11254664B2Feb 22, 2022
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC7 citations84
US10570153B2Feb 25, 2020
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC4 citations84
US12006326B2Jun 11, 2024
Antiviral heterocyclic compounds
ENANTA PHARM INC3 citations73
US11945830B2Apr 2, 2024
Antiviral heterocyclic compounds
ENANTA PHARM INC3 citations72
US9221878B2Dec 29, 2015
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC3 citations63
US12297209B2May 13, 2025
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations62
US11952389B2Apr 9, 2024
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations62
US10906895B2Feb 2, 2021
Processes for the preparation of benzodiazepine derivatives
ENANTA PHARM INC0 citations62
US12509470B2Dec 30, 2025
Antiviral heterocyclic compounds
ENANTA PHARM INC0 citations61
US12162857B2Dec 10, 2024
Antiviral compounds
ENANTA PHARM INC1 citations61
US12268694B2Apr 8, 2025
Combination pharmaceutical agents as RSV inhibitors
ENANTA PHARM INC0 citations59
US10881666B2Jan 5, 2021
Combination pharmaceutical agents as RSV inhibitors
ENANTA PHARM INC0 citations59
US8906853B2Dec 9, 2014
[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
ENANTA PHARM INC2 citations58
US11945824B2Apr 2, 2024
Heterocyclic compounds as anti-viral agents
ENANTA PHARM INC0 citations52
US11534439B2Dec 27, 2022
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations52
US11179400B2Nov 23, 2021
Heterocyclic compounds as RSV inhibitors
ENANTA PHARM INC0 citations52
US9669095B2Jun 6, 2017
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC1 citations52
US9616099B2Apr 11, 2017
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC0 citations52
US9242974B2Jan 26, 2016
Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
ENANTA PHARM INC0 citations52
US8921573B2Dec 30, 2014
Processes for the preparation of novel benzimidazole derivatives
ENANTA PHARM INC2 citations52
US8354383B2Jan 15, 2013
6,11-bridged biaryl macrolides
ENANTA PHARM INC1 citations52
US11091501B2Aug 17, 2021
Heterocyclic compounds as RSV inhibitors
ENANTA PHARM INC0 citations51
US10975094B2Apr 13, 2021
Heterocyclic compounds as RSV inhibitors
ENANTA PHARM INC0 citations51
US12358921B2Jul 15, 2025
Antiviral heterocyclic compounds
ENANTA PHARM INC0 citations50
US8927739B2Jan 6, 2015
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
ENANTA PHARM INC0 citations42
US10851115B2Dec 1, 2020
Heterocyclic compounds as RSV inhibitors
ENANTA PHARM INC0 citations41
US10752598B2Aug 25, 2020
Aryldiazepine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations41
US10647711B2May 12, 2020
Azepin-2-one derivatives as RSV inhibitors
ENANTA PHARM INC0 citations41
US10759816B2Sep 1, 2020
Heterocyclic compounds as RSV inhibitors
ENANTA PHARM INC0 citations40
SLOAN KETTERING INST CANCER
4 patentsUS6090789AJul 18, 2000
Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof
SLOAN KETTERING INST CANCER20 citations91
US6544952B1Apr 8, 2003
Synthesis of glycoconjugates of the globo-H epitope and uses thereof
SLOAN KETTERING INST CANCER43 citations90
US5708163AJan 13, 1998
Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
SLOAN KETTERING INST CANCER10 citations72
US6238668B1May 29, 2001
Colon cancer KH-1 and N3 antigens
SLOAN KETTERING INST CANCER13 citations71